President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Patient PortalAdult ClinicPediatricsEye CareMake an AppointmentBillingInfo for Healthcare Professionals
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Complications Research

Joslin investigators find innovative ways to predict, prevent and reverse diabetes complications through eye, kidney, vascular cell and insulin-producing beta cell studies.

Success in Sight with Diabetes

Joslin’s eye research team shows progress against the most feared complication of diabetes.

Lessons from the Long Haul in Diabetes

Joslin 50-Year Medalists, who often survive decades of diabetes with surprisingly few effects, begin to yield their secrets.

Culprit Found for Increased Stroke Injury with Diabetes

Finding may lead the way toward treatments that minimize adverse outcomes.

Diabetes May Clamp Down on Brain Cholesterol

Joslin research could help to explain changes in brain function among people with diabetes—including greater risk of Alzheimer’s disease.

Ultimate Diabetes Survivors, the Joslin 50-Year Medalists, Give Clues to Cures

In type 1 diabetes, the body relentlessly attacks and destroys its own insulin-producing pancreatic beta cells. But a study by Joslin scientists has firmly established that some of these cells endure for many decades in a small group of people with the disease—offering clues to potential treatments for preserving and even restoring the crucial cell population.

Joslin Lays Foundation for Improved Eye Treatment

If left untreated, about a quarter of people with diabetes eventually lose some of their vision from diabetic macular edema—a condition in which leaking blood vessels cause swelling in the center of the retina. While laser treatments based on work pioneered at Joslin in the 1960s have helped to minimize this damage, injecting a drug called ranibizumab can be more effective, according to results from a major clinical study by the Diabetes Retinopathy Clinical Research Network.


Page last updated: October 28, 2016